Michele De Palma

Immunology · 2005–2013

A researcher in the Science corpus: 4 papers; trusts 4 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 47 citations into it; #558 of 2,160 by trust here, #575 by citations
• Molecular Biology — 43 citations into it; #6,168 of 17,773 by trust here, #3,636 by citations
• Oncology — 33 citations into it

Whom Michele De Palma trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Pollard
2. Rakesh K. Jain
3. Binzhi Qian
4. M. Venneri
5. A. Mantovani
6. R. Galli
7. G. Bergers
8. T. Lawrence
9. F. Winkler
10. Lisa M. Coussens

Who trusts Michele De Palma overall

1. Chayanon Ngambenjawong
2. A. Mantovani
3. J. Pollard
4. Peter Carmeliet
5. Heather H Gustafson
6. R. Noy
7. B. Ruffell
8. P. Allavena
9. D. Quail
10. Li Yang

Papers from Michele De Palma's perspective

Ordered by how strongly the researchers Michele De Palma trusts endorse each paper. Same corpus, a different order for every researcher.

1. Tumour-educated macrophages promote tumour progression and metastasis (Nature Reviews. Cancer)
2. Origins of circulating endothelial cells and endothelial outgrowth from blood. (Journal of Clinical Investigation)
3. Macrophage Diversity Enhances Tumor Progression and Metastasis (Cell)
4. Angiogenesis in cancer and other diseases (Nature)
5. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. (Cancer Cell)
6. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. (Cancer Research)
7. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. (Cancer Cell)
8. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells (Nature Medicine)
9. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. (American Journal of Pathology)
10. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. (Cancer Cell)

Their papers

• Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. (2005) — 1,359 citations
• HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. (2011) — 705 citations
• Macrophage regulation of tumor responses to anticancer therapies. (2013) — 1,063 citations
• Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. (2011) — 633 citations